Moderna’s RSV Shot Faces CDC Drama

Moderna just got the green light for its RSV vaccine in younger at-risk adults, but now there’s drama: a new CDC panel (with some anti-vax vibes) might not back it. Their shares dropped, and everyone’s wondering if this new group will actually recommend the shot. Meanwhile, rival vaccine makers are feeling the heat too. Big pharma plot twist, anyone? #Moderna #RSVvaccine #CDC #Health #BodyHealth